Liver Injury after Autologous Hematopoietic Stem Cell Transplant: DILI and SOS
Conclusion: Liver injury associated with the autologous hematopoietic stem cell transplant, represented mainly by DILI and SOS, had a high incidence (18.9%) among the subjects in the study and was associated with an elevated mortality rate. Drug induced liver injury has been underestimated and deserves further studies.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - Category: Hematology Authors: Almeida, A. d. M., Cotrim, H. P., Fonseca, D. C., Alencar, D. M., Dutra, D. D., Santos, H. H. d. M., Botura, M., Salvino, M. A., Arruda, M. d. G. B. Tags: 731. Clinical Autologous Transplantation: Results: Poster I Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Allergy & Immunology | Bactrim | Bilirubin | Brazil Health | Chemotherapy | Cholestasis | Germ Cell Tumors | Hematology | Hepatitis | Hepatomegaly | Iron | Laboratory Medicine | Leukemia | Liver | Liver Disease | Liver Transplant | Lymphoma | Myeloma | Pain | Statistics | Stem Cell Therapy | Stem Cells | Study | Transplant Surgery | Transplants | Urology & Nephrology